Results 131 to 140 of about 6,976 (207)

Molnupiravir Treatment Associated With Clearance of Cache Valley Virus From Cerebrospinal Fluid in an Immunocompromised Child With Meningoencephalitis. [PDF]

Open Forum Infect Dis
Byrd DS, Ananth A, McDonald C, Atkinson TP, Chiu CY, Kimberlin DW, Marcus L.   +6 more
europepmc   +1 more source

Polymerase-inhibitor drug synergy and mutational signatures in different epithelial cell models of RSVA and hPIV3 infection. [PDF]

NPJ Antimicrob Resist
Ellis S, Jacobs AI, Zhang S, Buggiotti L, Woodall M, Ajeian J, Tutill H, Miller C, Palor M, Kopec A, Haughey EK, Ma H, Sharma A, Tomlinson M, Williams R, O'Callaghan C, Standing JF, Smith CM, Breuer J.   +18 more
europepmc   +1 more source

A randomized controlled Phase I de-escalation trial of molnupiravir and nirmatrelvir/ritonavir combination for mild-moderate SARS-CoV-2 infection. [PDF]

J Antimicrob Chemother
Khoo SH, FitzGerald R, Edwards CJ, Ahmad S, Saunders G, Else LJ, Shaw V, Mozgunov P, Northey J, Dickinson L, Knox E, Buadi A, Hale C, Reynolds HE, Middleton C, Bullock K, Walker L, Walker L, Tetlow M, Lyon R, Gibney J, Amara A, Greenhalf W, Burdon A, Dixon J, Jaki T, Chiong J, Lalloo DG, Owen A, Jacobs M, Fletcher T, Griffiths G, AGILE CST-8 study group .   +32 more
europepmc   +1 more source

Uridine cytidine kinases govern molnupiravir bioactivation and anti-SARS-CoV-2 activity. [PDF]

PLoS Pathog
Shu H, Ludäscher JM, Sharma S, Alam S, Frank L, Hutchinson ES, Tampere M, Lévêque C, van Kuilenburg ABP, Valerie NCK, Altun M, Chabes A, Stenmark P, Rudd SG, Zhang SM.   +14 more
europepmc   +1 more source

Antivirals Targeting Coronavirus RNA-Dependent RNA Polymerase and Main Protease: From Mechanisms of Action to Outcomes in COVID-19 Clinical Trials. [PDF]

Microb Biotechnol
Brüssow H.
europepmc   +1 more source

Effectiveness of nirmatrelvir/ritonavir and molnupiravir on post-COVID diabetes risk among an older adult cohort: a target trial emulation study. [PDF]

BMC Med
Guo Z, Wei Y, Yang A, Wong CKH, Xiong X, Wang K, Lin G, Wang H, Hung CT, Li C, Yam CHK, Chow TY, Zhao S, Mok CKP, Hui DSC, Yeoh EK, Chong KC.   +16 more
europepmc   +1 more source

Novel green UPLC method with life cycle assessment for determination of favipiravir and molnupiravir drugs and environmental water samples. [PDF]

Sci Rep
Kelani KM, Elsherbiny MS, Eid SM, Ghany MFA, Abbas MM.   +4 more
europepmc   +1 more source

Update on Treatment of Feline Infectious Peritonitis: European Advisory Board on Cat Diseases (ABCD) Guidelines. [PDF]

Viruses
Tasker S, Spiri AM, Hartmann K, Addie DD, Belák S, Bergmann M, Egberink H, Frymus T, Hofmann-Lehmann R, Marsilio F, Pennisi MG, Thiry E, Truyen U, Boucraut-Baralon C, Möstl K, Hosie MJ.   +15 more
europepmc   +1 more source

The 5'-Isobutyryl Ester Prodrug of 4'-Thiouridine Inhibits SARS-CoV‑2 Replication in Culture and in a Syrian Hamster Infection Model. [PDF]

ACS Omega
Chen Z, Amblard F, Kasthuri M, Tber Z, LeCher JC, Tao S, De R, Marko I, Bassit L, Zandi K, McBrayer T, Hurwitz SH, Weynand B, Abdelnabi R, Neyts J, Bhatt S, Boras B, Cardin RD, Zhu Y, Kapoor M, Eng H, Kalgutkar AS, Greenfield SR, Thakare R, King-Ahmad A, Patel NC, Johnson KA, Hepworth D, Fensome A, Schinazi RF.   +29 more
europepmc   +1 more source

Patterns of use of oral antivirals for COVID-19 in people 70 years and over in Victoria, Australia: a linked data study. [PDF]

BMC Infect Dis
Edwards LJ, Scaria A, Cheng AC, Amin J, Robinson EJ, Sumpton C, Liu B.   +6 more
europepmc   +1 more source